Stock listing
KRX:475960 Tomocube, Inc. (토모큐브) 주가
Follow Tomocube, Inc. into a list and get an email when it puts out news.
Share price · KRX:475960
₩20,950 KRW -1,350 (-6.1%)
Close on Nov 20, 2026
- Day range
- ₩20,650 – ₩22,000 KRWNov 20, 2026
- Volume
- 48,617 sharesNov 20, 2026
- Market cap
- ₩280.4B KRWAt the close on Nov 20, 2026 · price × 13.38M shares outstanding
- 52-week range
- ₩20,650 – ₩67,800 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩1.27B KRWMedian day 32,775 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:475960 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩20,950 | -1,350 | -6.1% | ₩22,000 | ₩22,000 | ₩20,650 | 48,617 | |
| ₩22,300 | -600 | -2.6% | ₩22,950 | ₩23,450 | ₩20,950 | 127,318 | |
| ₩22,900 | -1,800 | -7.3% | ₩24,100 | ₩24,500 | ₩22,150 | 79,686 | |
| ₩24,700 | -700 | -2.8% | ₩25,650 | ₩25,650 | ₩24,100 | 33,700 | |
| ₩25,400 | -3,050 | -10.7% | ₩28,350 | ₩29,350 | ₩24,500 | 139,051 | |
| ₩28,450 | -500 | -1.7% | ₩28,500 | ₩29,050 | ₩27,700 | 28,646 | |
| ₩28,950 | +2,800 | +10.7% | ₩26,150 | ₩30,600 | ₩26,150 | 113,666 | |
| ₩26,150 | +650 | +2.5% | ₩26,500 | ₩26,800 | ₩25,300 | 39,813 | |
| ₩25,500 | +650 | +2.6% | ₩25,250 | ₩26,100 | ₩24,350 | 28,551 | |
| ₩24,850 | -1,950 | -7.3% | ₩24,700 | ₩26,150 | ₩23,300 | 37,101 | |
| ₩26,800 | -700 | -2.5% | ₩28,150 | ₩28,550 | ₩26,700 | 31,785 | |
| ₩27,500 | -1,100 | -3.8% | ₩29,000 | ₩29,350 | ₩26,300 | 62,313 | |
| ₩28,600 | -1,000 | -3.4% | ₩29,600 | ₩29,700 | ₩28,400 | 18,804 | |
| ₩29,600 | -900 | -3.0% | ₩30,400 | ₩30,450 | ₩29,400 | 18,544 | |
| ₩30,500 | -2,150 | -6.6% | ₩31,150 | ₩31,750 | ₩29,700 | 31,979 | |
| ₩32,650 | +700 | +2.2% | ₩31,950 | ₩34,150 | ₩31,550 | 53,971 | |
| ₩31,950 | +550 | +1.8% | ₩31,500 | ₩32,100 | ₩30,450 | 32,343 | |
| ₩31,400 | +50 | +0.2% | ₩31,650 | ₩33,000 | ₩31,350 | 36,811 | |
| ₩31,350 | +1,250 | +4.2% | ₩30,100 | ₩32,500 | ₩29,500 | 48,475 | |
| ₩30,100 | -300 | -1.0% | ₩29,700 | ₩30,300 | ₩28,600 | 21,031 | |
| ₩30,400 | -700 | -2.3% | ₩31,000 | ₩31,300 | ₩30,050 | 16,885 | |
| ₩31,100 | +600 | +2.0% | ₩30,600 | ₩31,750 | ₩30,600 | 23,178 | |
| ₩30,500 | -1,000 | -3.2% | ₩31,200 | ₩31,500 | ₩30,050 | 18,919 | |
| ₩31,500 | +250 | +0.8% | ₩29,850 | ₩31,500 | ₩29,800 | 32,427 | |
| ₩31,250 | +2,250 | +7.8% | ₩29,050 | ₩31,750 | ₩29,050 | 30,045 | |
| ₩29,000 | -2,200 | -7.1% | ₩30,000 | ₩30,300 | ₩28,300 | 44,755 | |
| ₩31,200 | -50 | -0.2% | ₩31,450 | ₩32,400 | ₩30,600 | 33,320 | |
| ₩31,250 | -1,050 | -3.3% | ₩31,400 | ₩31,800 | ₩30,350 | 46,798 | |
| ₩32,300 | -950 | -2.9% | ₩32,850 | ₩33,700 | ₩32,000 | 39,250 | |
| ₩33,250 | -1,250 | -3.6% | ₩33,950 | ₩35,550 | ₩33,200 | 48,341 | |
| ₩34,500 | -1,400 | -3.9% | ₩36,450 | ₩36,450 | ₩33,850 | 66,040 | |
| ₩35,900 | +1,600 | +4.7% | ₩35,000 | ₩36,500 | ₩34,650 | 41,765 | |
| ₩34,300 | -2,650 | -7.2% | ₩36,900 | ₩36,900 | ₩34,050 | 74,412 | |
| ₩36,950 | +1,950 | +5.6% | ₩34,800 | ₩37,500 | ₩33,900 | 86,298 | |
| ₩35,000 | +3,200 | +10.1% | ₩32,000 | ₩36,450 | ₩32,000 | 113,951 | |
| ₩31,800 | +450 | +1.4% | ₩30,650 | ₩32,550 | ₩29,800 | 53,784 | |
| ₩31,350 | +3,500 | +12.6% | ₩28,800 | ₩32,600 | ₩28,500 | 138,115 | |
| ₩27,850 | +550 | +2.0% | ₩27,400 | ₩28,050 | ₩27,250 | 15,718 | |
| ₩27,300 | -300 | -1.1% | ₩27,700 | ₩28,100 | ₩27,050 | 14,562 | |
| ₩27,600 | +50 | +0.2% | ₩27,400 | ₩27,850 | ₩26,900 | 14,412 | |
| ₩27,550 | -500 | -1.8% | ₩28,100 | ₩28,200 | ₩27,300 | 19,535 | |
| ₩28,050 | +550 | +2.0% | ₩27,300 | ₩28,350 | ₩27,300 | 14,452 | |
| ₩27,500 | +650 | +2.4% | ₩26,700 | ₩27,600 | ₩26,000 | 31,863 | |
| ₩26,850 | +100 | +0.4% | ₩27,000 | ₩27,400 | ₩26,350 | 15,238 | |
| ₩26,750 | -500 | -1.8% | ₩27,250 | ₩27,350 | ₩26,350 | 28,555 | |
| ₩27,250 | -400 | -1.4% | ₩27,050 | ₩27,800 | ₩26,800 | 17,104 | |
| ₩27,650 | -800 | -2.8% | ₩27,900 | ₩28,000 | ₩27,100 | 24,094 | |
| ₩28,450 | -150 | -0.5% | ₩28,150 | ₩29,000 | ₩28,150 | 11,407 | |
| ₩28,600 | +400 | +1.4% | ₩29,000 | ₩29,300 | ₩28,350 | 22,388 | |
| ₩28,200 | +100 | +0.4% | ₩28,400 | ₩28,900 | ₩27,100 | 31,530 | |
| ₩28,100 | +850 | +3.1% | ₩27,250 | ₩28,600 | ₩26,300 | 33,765 | |
| ₩27,250 | -1,350 | -4.7% | ₩29,400 | ₩29,400 | ₩26,650 | 50,998 | |
| ₩28,600 | -850 | -2.9% | ₩28,800 | ₩29,250 | ₩28,300 | 21,240 | |
| ₩29,450 | -1,050 | -3.4% | ₩30,500 | ₩30,700 | ₩29,000 | 33,300 | |
| ₩30,500 | +450 | +1.5% | ₩29,800 | ₩30,500 | ₩28,800 | 32,733 | |
| ₩30,050 | -750 | -2.4% | ₩31,850 | ₩31,850 | ₩29,900 | 23,224 | |
| ₩30,800 | -1,100 | -3.4% | ₩31,900 | ₩31,900 | ₩30,550 | 22,774 | |
| ₩31,900 | +650 | +2.1% | ₩31,500 | ₩32,200 | ₩31,200 | 26,169 | |
| ₩31,250 | -1,250 | -3.8% | ₩32,000 | ₩32,550 | ₩30,250 | 32,816 | |
| ₩32,500 | +3,650 | +12.7% | ₩29,350 | ₩32,950 | ₩29,150 | 65,653 | |
| ₩28,850 | -1,950 | -6.3% | ₩30,500 | ₩30,500 | ₩28,750 | 61,054 | |
| ₩30,800 | -750 | -2.4% | ₩32,100 | ₩33,750 | ₩30,600 | 51,390 |
- Ticker
- KRX:475960
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
Tomocube, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- Decks
- 4 decks · latest May 30, 2025
Valuation
EV/sales 16.6× against a median of 3.8×: 10th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩252.0B KRW
- P/E
- Loss
- EV/sales
- 16.6×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 7.4×
- Gross margin
- 64.5%
- Operating margin
- −25.5%
- Net margin
- −16.1%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Tomocube, Inc. · KRX:475960 | US$208.3M | US$187.2M | n/a | 16.6× | n/a | 7.4× | −16.1% | 0.0× | n/a |
| Jiangsu Cowin Biotech Co., Ltd. Class A · SSE:688426 | US$250.1M | US$138.3M | n/a | 4.0× | n/a | 1.3× | −35.4% | 0.0× | n/a |
| Lifecore Biomedical, Inc. · NASDAQ:LFCR | US$242.2M | US$380.1M | n/a | 2.9× | 46.1× | n/a | −23.8% | n/a | 0.51 |
| OraSure Technologies, Inc. · NASDAQ:OSUR | US$238.9M | US$102.3M | n/a | 0.9× | n/a | 0.8× | −41.7% | 0.0× | 1.21 |
| Shanghai Rendu Biotechnology Co., Ltd. Class A · SSE:688193 | US$216.7M | US$100.3M | 64.7× | 4.2× | n/a | 1.6× | 13.9% | 0.0× | n/a |
| Median Technologies · EURONEXT:ALMDT | US$214.8M | US$176.5M | n/a | 6.9× | n/a | n/a | −145.8% | n/a | n/a |
| Guangzhou LBP Medicine Science & Technology Co., Ltd. Class A · SSE:688393 | US$195.9M | US$151.2M | n/a | 2.8× | n/a | 1.2× | −9.2% | 0.0× | n/a |
| Dishman Carbogen Amcis Ltd. · NSE:DCAL | US$195.5M | US$195.5M | 26.6× | 0.8× | 4.2× | 0.3× | 3.0% | 0.0× | n/a |
| Quantum-Si Incorporated · NASDAQ:QSI | US$180.8M | US$80.11M | n/a | 63.3× | n/a | 1.1× | n/a | 0.0× | 3.19 |
| Tarsons Products Limited · NSE:TARSONS | US$174.2M | US$174.2M | 146× | 3.7× | 13.5× | 2.5× | 2.5% | 0.0× | n/a |
| AVE Science & Technology Co., Ltd. Class A · SSE:688067 | US$170.2M | US$138.2M | 33.8× | 3.9× | n/a | 2.1× | 14.3% | 0.0× | n/a |
| Median of the others | US$205.4M | US$144.8M | 49.2× | 3.8× | 13.5× | 1.2× | −9.2% | 0.0× | 1.21 |
Forecasts
Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- EPS, year to Dec 2026
- 271.00 · 1 analyst
- Revenue, year to Dec 2026
- 23B · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| YongKeun Park | Chief Executive Officer, Chair of the Board of Directors |
| SungHo Ko | Chief Operating Officer, Director |
Board
| Director | Role |
|---|---|
| Bernard K. Ham | Director |
| Sang-Hoon Cha | Director |
| Sang-il Park | Director |
| SungHo Ko | Chief Operating Officer, Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2025 Earnings Presentation | Earnings | 39 slides | May 30, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 40 slides | May 23, 2025 |
| Investor Presentation (December 2024) | Investor deck | 43 slides | Dec 5, 2024 |
| Investor Presentation (October 2024) | Investor deck | 46 slides | Oct 15, 2024 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.3B | 5.94B | 3.75B | 1.87B | 1.63B |
| Cost of revenue | 3.86B | 2.35B | 1.57B | 928.4M | 959.1M |
| Gross profit | 7.44B | 3.59B | 2.18B | 942.7M | 666.1M |
| Research and development | 5.22B | 5.47B | 3.67B | 3.24B | 3.77B |
| Selling, general and administrative | 2.83B | 6.26B | 4.76B | 3.84B | 828.5M |
| Operating income | -5.57B | -8.78B | -6.73B | -6.37B | -6.41B |
| Depreciation and amortization | 1.51B | 1.07B | 1.02B | 611.2M | 596.6M |
| EBITDA | -4.06B | -7.70B | -5.71B | -5.76B | -5.81B |
| Interest expense | 72.2M | 65.9M | 5.12B | 4.34B | 2.77B |
| Income before tax | -4.81B | -8.30B | -23.6B | 29.3B | -19.3B |
| Net income | -4.81B | -8.30B | -23.6B | 29.3B | -19.3B |
| Earnings per share, basic | -359.40 | -636.32 | -1,849.80 | 2,304.29 | -1,813.18 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 11.4B | 12.7B | 2.85B | 1.53B | 18.2B |
| Short-term investments | 17.2B | 23.0B | 9.49B | 17.2B | 8.02B |
| Receivables | 2.87B | 1.49B | 1.01B | 336.9M | 243.3M |
| Inventory | 3.59B | 2.38B | 2.27B | 2.79B | 1.07B |
| Current assets | 35.7B | 40.1B | 16.0B | 22.1B | 27.7B |
| Property, plant and equipment | 2.85B | 3.14B | 2.23B | ||
| Total assets | 41.5B | 43.6B | 19.8B | 25.1B | 30.0B |
| Accounts payable | 276.7M | 21.1M | 59.7M | 251.2M | 261.1M |
| Current liabilities | 1.54B | 1.33B | 1.78B | 52.2B | 87.8B |
| Long-term debt | 0 | 0 | 300.0M | ||
| Total liabilities | 2.72B | 1.62B | 2.07B | 52.9B | 88.2B |
| Shareholders' equity | 38.8B | 42.0B | 17.7B | -27.8B | -58.3B |
| Shares outstanding | 13.4M | 13.0M | 12.7M | 12.7M | 10.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | -6.75B | -6.54B | -5.93B | -6.75B | -4.42B |
| Capital spending | -773.6M | -934.3M | -231.5M | -568.9M | -645.6M |
| Free cash flow | -7.53B | -7.47B | -6.16B | -7.32B | -5.07B |
| Cash from investing | -14.4B | 7.47B | -9.77B | ||
| Cash from financing | 30.7B | -182.2M | -156.6M | ||
| Share buybacks | 33.3B | ||||
| Change in cash | -1.24B | 9.84B | 1.33B | -16.7B | 8.07B |
Cap table
Built by 6ix from Tomocube, Inc.’s releases
- Common shares
- 13,383,274
- Fully diluted
- 13,383,274
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 13,383,274 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 13,383,274 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bernard K. Ham | Director · Since at least Nov 5, 2026 |
| Sang-Hoon Cha | Director · Since at least Nov 5, 2026 |
| Sang-il Park | Director · Since at least Nov 5, 2026 |
| SungHo Ko | Chief Operating Officer, Director · Since at least Nov 5, 2026 |
| YongKeun Park | Chief Executive Officer, Chair of the Board of Directors · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Tomocube, Inc.